Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation.

Antonella GaleoneJoe-Elie SalemGuillaume LebretonGuillaume Coutance Lee S NguyenJean Sébastien HulotFabrice AtassiMarco BegaPascal LeprinceShaida Varnous

Published in: Clinical transplantation (2022)

Higher sST2 levels in donors are associated to allograft dysfunction requiring ECMO in recipients; higher postoperative sST2 levels in recipients are associated with in-hospital mortality.

Keyphrases

kidney transplantation
extracorporeal membrane oxygenation
patients undergoing
acute respiratory distress syndrome
intensive care unit